Crystal MacKall

Title: Crystal MacKall: Innovator in Cancer Treatment

Introduction

Crystal MacKall is a prominent inventor based in Silver Spring, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of immunogenic peptides. Her work aims to enhance the effectiveness of cancer therapies and improve patient outcomes.

Latest Patents

Crystal MacKall holds a patent for "Immunogenic peptides and methods of use for treating and preventing cancer." This patent encompasses a range of immunogenic peptides, related fusion proteins, and nucleic acids encoding these peptides or fusion proteins. Additionally, it includes conjugates, expression vectors, host cells, and antibodies. The patent also details pharmaceutical compositions and vaccines designed for the treatment or prevention of cancer, specifically targeting conditions such as alveolar rhabdomyosarcoma. Methods for stimulating T cells to kill tumor cells and treating or preventing cancer are further elaborated in her patent.

Career Highlights

Crystal MacKall is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has been instrumental in advancing cancer research and developing new therapeutic strategies.

Collaborations

Throughout her career, Crystal has collaborated with notable colleagues, including Jay A Berzofsky and Leon T Van Den Broeke. These partnerships have contributed to her success in the field of cancer immunotherapy.

Conclusion

Crystal MacKall's innovative work in immunogenic peptides represents a significant advancement in cancer treatment. Her contributions continue to inspire further research and development in the fight against cancer.